The biology and role of CD44 in cancer progression: therapeutic implications.
Chen C, Zhao S, Karnad A, Freeman JW. · 2018
Read The biology and role of CD44 in cancer progression: therapeutic implications. by Chen C, Zhao S, Karnad A, Freeman JW. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5946470.txt.
Description
Chen and co-authors review the biology of CD44 and its role in cancer progression. Their review appeared in the Journal of Hematology & Oncology. CD44 is a transmembrane glycoprotein found on many cell types. It is overexpressed on cancer stem cells. Its main ligand, hyaluronan, switches on signalling pathways. Those pathways drive cell growth, survival, and movement.
Variant forms of CD44 add peptide motifs to the standard form. These variants can hold growth factors at the cell surface. They were found in metastasized tumours, the authors note. Switching between forms may steer epithelial to mesenchymal transition. The review covers CD44 regulation and its promise as a therapy target.
Catalog record
| CREATOR | Chen C, Zhao S, Karnad A, Freeman JW. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 129 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |